Skip to main content
. 2023 Mar 20;14:1545. doi: 10.1038/s41467-023-37035-5

Fig. 5. Schematic representation of in solution dynamics of SARS-CoV-2 C145S Mpro monomeric form (sample 1) analyzed with SEC-MALS.

Fig. 5

a Control reaction containing monomers at 0 h (top), after 24 h incubation (middle) and after 48 h (bottom). b Monomers conversion reaction in presence of non-covalent inhibitor MAT-POS-e194df51-1 at 0 h (top), after 24 h incubation (middle) and after 48 h (bottom). c Monomers conversion reaction in presence of covalent inhibitor Nirmatrelvir at 0 h (top), after 24 h incubation (middle) and after 48 h (bottom).